Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Eur J Clin Invest ; 47(5): 394-397, 2017 May.
Article in English | MEDLINE | ID: mdl-28369858

ABSTRACT

BACKGROUND: New treatments in coeliac disease are being vigorously pursued to either replace or facilitate the difficult-tofollow gluten-free diet. DESIGN: The present review intends to summarise the challenges in gluten-free diet adherence during the transitional period, as reflected in the last Prague consensus, published in 2016. RESULTS: The honourable panel members recommended that dietary adherence and the consequences of nonadherence represent key components for discussion in the transitional period setting. CONCLUSIONS: There are numerous difficulties in adhering to gluten withdrawal, but the transition period from adolescence to young adulthood is considered a fragile and high-risk period for intentional and unintentional gluten intake.


Subject(s)
Celiac Disease/diet therapy , Diet, Gluten-Free , Patient Compliance , Adolescent , Age Factors , Consensus , Humans , Practice Guidelines as Topic , Young Adult
3.
Med Microbiol Immunol ; 206(2): 83-91, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28204873

ABSTRACT

Celiac disease remains one of the most challenging pathologies of the small intestine. It involves multiple pathogenic pathways and there are no disease-changing pharmacological agents available against it yet. The term microbiota refers to the community of microorganisms that inhabit a particular region of the body. Normal gut microbiota has a vital role in maintaining the intestinal homeostasis and promoting health. Celiac disease is associated with microbiota alteration, especially with an increase in the number of Gram-negative bacteria and a decrease in the number of Gram-positive bacteria. There is a strong relationship between intestinal dysbiosis and celiac disease, and recent studies are aimed at determining whether the celiac disease is a risk factor for dysbiosis or dysbiosis is for celiac disease. Therefore, the aim of this review was to assess the latest findings regarding the gut microbiota and its impact on the celiac disease, including therapeutic aspects.


Subject(s)
Celiac Disease/etiology , Dysbiosis , Celiac Disease/metabolism , Celiac Disease/therapy , Diet, Gluten-Free , Gastrointestinal Microbiome , Genetic Predisposition to Disease , Genotype , HLA Antigens/genetics , HLA Antigens/immunology , Host-Pathogen Interactions , Humans , Immunity, Mucosal , Immunomodulation , Intestinal Mucosa/immunology , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Life Style , Probiotics/administration & dosage , Probiotics/therapeutic use , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL